A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility
- PMID: 18347327
- PMCID: PMC2336811
- DOI: 10.1101/gr.074914.107
A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility
Abstract
Insulin resistance is necessary but not sufficient for the development of type 2 diabetes. Diabetes results when pancreatic beta-cells fail to compensate for insulin resistance by increasing insulin production through an expansion of beta-cell mass or increased insulin secretion. Communication between insulin target tissues and beta-cells may initiate this compensatory response. Correlated changes in gene expression between tissues can provide evidence for such intercellular communication. We profiled gene expression in six tissues of mice from an obesity-induced diabetes-resistant and a diabetes-susceptible strain before and after the onset of diabetes. We studied the correlation structure of mRNA abundance and identified 105 co-expression gene modules. We provide an interactive gene network model showing the correlation structure between the expression modules within and among the six tissues. This resource also provides a searchable database of gene expression profiles for all genes in six tissues in lean and obese diabetes-resistant and diabetes-susceptible mice, at 4 and 10 wk of age. A cell cycle regulatory module in islets predicts diabetes susceptibility. The module predicts islet replication; we found a strong correlation between (2)H(2)O incorporation into islet DNA in vivo and the expression pattern of the cell cycle module. This pattern is highly correlated with that of several individual genes in insulin target tissues, including Igf2, which has been shown to promote beta-cell proliferation, suggesting that these genes may provide a link between insulin resistance and beta-cell proliferation.
Figures
References
-
- Burcelin R., Mrejen C., Decaux J.F., De Mouzon S.H., Girard J., Charron M.J., Mrejen C., Decaux J.F., De Mouzon S.H., Girard J., Charron M.J., Decaux J.F., De Mouzon S.H., Girard J., Charron M.J., De Mouzon S.H., Girard J., Charron M.J., Girard J., Charron M.J., Charron M.J. In vivo and in vitro regulation of hepatic glucagon receptor mRNA concentration by glucose metabolism. J. Biol. Chem. 1998;273:8088–8093. - PubMed
-
- Busch R., Cesar D., Higuera-Alhino D., Gee T., Hellerstein M.K., McCune J.M., Cesar D., Higuera-Alhino D., Gee T., Hellerstein M.K., McCune J.M., Higuera-Alhino D., Gee T., Hellerstein M.K., McCune J.M., Gee T., Hellerstein M.K., McCune J.M., Hellerstein M.K., McCune J.M., McCune J.M. Isolation of peripheral blood CD4+ T cells using RosetteSep and MACS for studies of DNA turnover by deuterium labeling. J. Immunol. Methods. 2004;286:97–109. - PubMed
-
- Carlson M.R., Zhang B., Fang Z., Mischel P.S., Horvath S., Nelson S.F., Zhang B., Fang Z., Mischel P.S., Horvath S., Nelson S.F., Fang Z., Mischel P.S., Horvath S., Nelson S.F., Mischel P.S., Horvath S., Nelson S.F., Horvath S., Nelson S.F., Nelson S.F. Gene connectivity, function, and sequence conservation: Predictions from modular yeast co-expression networks. BMC Genomics. 2006;7:40. doi: 10.1186/1471-2164-7-40. - DOI - PMC - PubMed
-
- Cozar-Castellano I., Fiaschi-Taesch N., Bigatel T.A., Takane K.K., Garcia-Ocana A., Vasavada R., Stewart A.F., Fiaschi-Taesch N., Bigatel T.A., Takane K.K., Garcia-Ocana A., Vasavada R., Stewart A.F., Bigatel T.A., Takane K.K., Garcia-Ocana A., Vasavada R., Stewart A.F., Takane K.K., Garcia-Ocana A., Vasavada R., Stewart A.F., Garcia-Ocana A., Vasavada R., Stewart A.F., Vasavada R., Stewart A.F., Stewart A.F. Molecular control of cell cycle progression in the pancreatic beta-cell. Endocr. Rev. 2006;27:356–370. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous